DGAP-Stimmrechte: RHÖN-KLINIKUM AG (english)

RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG

[the German Securities Trading Act] with the objective of Europe-wide

distribution



RHÖN-KLINIKUM AG



05.07.2012 14:32



Dissemination of a Voting Rights Announcement, transmitted by

DGAP - a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------





Notification according to section 26 para. 1 WpHG



Morgan Stanley & Co International Plc, London, UK, Morgan Stanley UK Group,

London, UK, Morgan Stanley Group (Europe), London, UK, Morgan Stanley

International Limited, London, UK, Morgan Stanley International Holdings

Inc, Delaware, USA, and Morgan Stanley, Delaware, USA notified us pursuant

to section 25a WpHG of the following:



1) On 27 June 2012, Morgan Stanley & Co International Plc fell below the

threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite

1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley &

Co International Plc held 0.07% of the voting rights in RHÖN-KLINIKUM AG

(equals 99,226 voting rights).



From these voting rights a proportion of 0.00% (equals 0 voting rights) is

based on voting rights pursuant to sections 21, 22 WpHG.



In addition, a proportion of 0.06% (equals 85.500 voting rights) is based

on (financial/other) instruments pursuant to section 25 WpHG. From the

voting rights based on instruments pursuant to section 25 WpHG a proportion

of 0.06% (equals 85,500 voting rights) is held indirectly.



In addition, a proportion of 0.01% (equals 13,726 voting rights) is based

on (financial/other) instruments pursuant to section 25a WpHG. From the

voting rights based on instruments pursuant to section 25a WpHG a

proportion of 0.00% (equals 0 voting rights) is held indirectly. The

instruments pursuant to section 25a WpHG are 'Cash-Settled Swaps'

(expiration date: 31 October 2013).



2) On 27 June 2012, Morgan Stanley UK Group fell below the threshold of 5%

of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad

Neustadt a. d. Saale, Germany. On that date Morgan Stanley UK Group held

0.07% of the voting rights in RHÖN-KLINIKUM AG (equals 99,226 voting

rights).



From these voting rights a proportion of 0.00% (equals 0 voting rights) is

based on voting rights pursuant to sections 21, 22 WpHG.



In addition, a proportion of 0.06% (equals 85,500 voting rights) is based

on (financial/other) instruments pursuant to section 25 WpHG. From the

voting rights based on instruments pursuant to section 25 WpHG a proportion

of 0.06% (equals 85,500 voting rights) is held indirectly.



In addition, a proportion of 0.01% (equals 13,726 voting rights) is based

on (financial/other) instruments pursuant to section 25a WpHG. From the

voting rights based on instruments pursuant to section 25a WpHG a

proportion of 0.01% (equals 13,726 voting rights) is held indirectly (chain

of controlled undertakings: Morgan Stanley & Co International Plc). The

instruments pursuant to section 25a WpHG are 'Cash-Settled Swaps'

(expiration date: 31 October 2013).



3) On 27 June 2012, Morgan Stanley Group (Europe) fell below the threshold

of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616

Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley Group

(Europe) held 0.07% of the voting rights in RHÖN-KLINIKUM AG (equals 99,226

voting rights).



From these voting rights a proportion of 0.00% (equals 0 voting rights) is

based on voting rights pursuant to sections 21, 22 WpHG.



In addition, a proportion of 0.06% (equals 85,500 voting rights) is based

on (financial/other) instruments pursuant to section 25 WpHG. From the

voting rights based on instruments pursuant to section 25 WpHG a proportion

of 0.06% (equals 85,500 voting rights) is held indirectly.



In addition, a proportion of 0.01% (equals 13,726 voting rights) is based

on (financial/other) instruments pursuant to section 25a WpHG. From the

voting rights based on instruments pursuant to section 25a WpHG a

proportion of 0.01% (equals 13,726 voting rights) is held indirectly (chain

of controlled undertakings: Morgan Stanley UK Group; Morgan Stanley & Co

International Plc). The instruments pursuant to section 25a WpHG are

'Cash-Settled Swaps' (expiration date: 31 October 2013).



4) On 27 June 2012, Morgan Stanley International Limited fell below the

threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite

1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley

International Limited held 0.07% of the voting rights in RHÖN-KLINIKUM AG

(equals 99,226 voting rights).



From these voting rights a proportion of 0.00% (equals 0 voting rights) is

based on voting rights pursuant to sections 21, 22 WpHG.



In addition, a proportion of 0.06% (equals 85,500 voting rights) is based

on (financial/other) instruments pursuant to section 25 WpHG. From the

voting rights based on instruments pursuant to section 25 WpHG a proportion

of 0.06% (equals 85,500 voting rights) is held indirectly.



In addition, a proportion of 0.01% (equals 13,726 voting rights) is based

on (financial/other) instruments pursuant to section 25a WpHG. From the

voting rights based on instruments pursuant to section 25a WpHG a

proportion of 0.01% (equals 13,726 voting rights) is held indirectly (chain

of controlled undertakings: Morgan Stanley Group (Europe); Morgan Stanley

UK Group; Morgan Stanley & Co International Plc). The instruments pursuant

to section 25a WpHG are 'Cash-Settled Swaps' (expiration date: 31 October

2013).



5) On 27 June 2012, Morgan Stanley International Holdings Inc fell below

the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger

Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan

Stanley International Holdings Inc held 0.13% of the voting rights in

RHÖN-KLINIKUM AG (equals 184,726 voting rights).



From these voting rights a proportion of 0.06% (equals 85,500 voting

rights) is based on voting rights pursuant to sections 21, 22 WpHG



In addition, a proportion of 0.06% (equals 85,500 voting rights) is based

on (financial/other) instruments pursuant to section 25 WpHG. From the

voting rights based on instruments pursuant to section 25 WpHG a proportion

of 0.06% (equals 85,500 voting rights) is held indirectly.



In addition, a proportion of 0.01% (equals 13.726 voting rights) is based

on (financial/other) instruments pursuant to section 25a WpHG. From the

voting rights based on instruments pursuant to section 25a WpHG a

proportion of 0.01% (equals 13,726 voting rights) is held indirectly (chain

of controlled undertakings: Morgan Stanley International Limited; Morgan

Stanley Group (Europe); Morgan Stanley UK Group; Morgan Stanley & Co

International Plc). The instruments pursuant to section 25a WpHG are

'Cash-Settled Swaps' (expiration date: 31 October 2013).



6) On 27 June 2012, Morgan Stanley fell below the threshold of 5% of the

voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt

a. d. Saale, Germany. On that date, Morgan Stanley held 0.37% of the voting

rights in RHÖN-KLINIKUM AG (equals 516,012 voting rights).



From these voting rights a proportion of 0.24% (equals 338,139 voting

rights) is based on voting rights pursuant to sections 21, 22 WpHG.



In addition, a proportion of 0.11% (equals 158,867 voting rights) is based

on (financial/other) instruments pursuant to section 25 WpHG. From the

voting rights based on instruments pursuant to section 25 WpHG a proportion

of 0.11% (equals 158,867 voting rights) is held indirectly.



In addition, a proportion of 0.01% (equals 19,006 voting rights) is based

on (financial/other) instruments pursuant to section 25a WpHG. From the

voting rights based on instruments pursuant to section 25a WpHG a

proportion of 0.01% (equals 13,726 voting rights) is held indirectly (chain

of controlled undertakings: Morgan Stanley International Holdings Inc;

Morgan Stanley International Limited; Morgan Stanley Group (Europe); Morgan

Stanley UK Group; Morgan Stanley & Co International Plc). The instruments

pursuant to section 25a WpHG are 'Cash-Settled Swaps' (expiration date: 31

October 2013) and 'Cash Settled Futures' (expiration date: 11 March 2013).



Bad Neustadt a.d. Saale, 5 July 2012



The Board of Management



___________________________________________________________________________



Dr. Kai G. Klinger

Head of Investor Relations

RHÖN-KLINIKUM AG

Schlossplatz 1

97616 Bad Neustadt a. d. Saale

Phone: +49 9771 65 - 1318

Fax: +49 9771 99 - 1736







05.07.2012 DGAP's Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de



---------------------------------------------------------------------------



Language: English

Company: RHÖN-KLINIKUM AG

Schlossplatz 1

97616 Bad Neustadt a.d.Saale

Germany

Internet: www.rhoen-klinikum-ag.com



End of Announcement DGAP News-Service



---------------------------------------------------------------------------









Weitere Informationen: www.dpa-AFX.de